Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT06541405 · UNKNOWN
Trial details
- NCT number
- NCT06541405
- Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.